简介：The simple answer is a resounding， unequivocal yes. There are two main elements. The first is that for people with NAFLD， the commonest cause of death is cardiovascular. The next commonest is actually common cancers. There is reasonable data that lipid-lowering therapy will reduce their risk of cardiovascular outcomes. They should be looked at as a group of patients at an unusually high risk of cardiovascular disease and their lipids should be treated aggressively.